Opioid Producers to Train Doctors

Share this content:
74 manufacturers of immediate-release opioids notified that drugs will be subject to requirements.
74 manufacturers of immediate-release opioids notified that drugs will be subject to requirements.

(HealthDay News) -- In an effort to halt the ongoing opioid addiction crisis, US regulators are requiring manufacturers to provide extensive training to doctors, according to a report published by the Associated Press.

Scott Gottleib, MD, commissioner of the US Food and Drug Administration, noted in a recent blog post that the FDA had informed 74 manufacturers of immediate-release opioids, including hydrocodone/acetaminophen and oxycodone/acetaminophen, that their drugs would be subject to these requirements. However, physicians will not be required to undergo training.

Overall, about 2 million individuals are addicted to prescription opioids in the United States. In 2015, more than 15,000 died of overdoses involving prescription opioids. Manufacturers of long-acting opioids, including oxycodone, have been subject to these requirements since 2012.

Gottleib called the drugs a "potential gateway to addiction" in the blog post.

Reference

FDA requires opioid makers to develop doctor training. Carla K. Johnson. Associated Press. Sep. 28, 2017.

You must be a registered member of Renal and Urology News to post a comment.